FHH – Cancer
FAMILY HEALTH HISTORY Cancer Overview CANCER A-Z Cancer is a large group of diseases that could happen in any organ or tissue of the body with uncontrollable growth of abnormal cells. These cells grow beyond the usual boundaries and invade the adjoining parts of the body and spread other than its primary sites. This process
FHH – Diabetes
FAMILY HEALTH HISTORY Diabetes Overview INTRODUCTION High-level introduction – Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse
What To Know About Genomics Education Week
What To Know About Healthcare Professionals’ Genomics Education Week We all understand the importance of implementing genomics and patient care, but healthcare providers may not be aware of the genomics education resources available. Our partners at the National Human Genome Research Institute, along with several of our colleagues, are organizing a social media campaign from
Duke CAGPM Genomic & Precision Medicine Forum Series
Upcoming Talk: “Genetic and Molecular Determinants Associated with Dropout from and Adherence to Lifestyle Interventions” will be presented by Katherine Collins, PhD, and “AR-pathway-inhibitor resistant prostate cancer: A Systems Biology Approach” will be presented by Nathan Hawkey, MD, on Thursday, May 12, 2022. Registration is required.
Evidence Working Group’s Published Article on Polygenic Risk Scores in Genomic Medicine Practices
G2MC Evidence Working Group Publish Systemic Review New Review published online in Human Genetics as part of the Springer Nature Content Sharing Initiative We are incredibly excited to announce that article “The clinical utility of polygenic risk scores in genomic medicine practices: a systematic review” has been published online in Human Genetics, led and authored
G2MC Accepting Steering Committee Nominations Through May 5
The Global Genomic Medicine Consortium (G2MC) is pleased to begin the nomination process for electing new members to the G2MC Steering Committee. Nominations are being accepted through May 5, 2022.